Compile Data Set for Download or QSAR
Report error Found 46 Enz. Inhib. hit(s) with all data for entry = 3370
TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398027BDBM398027(US10322108, Example 23)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398023BDBM398023(US10322108, Example 21A)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398025BDBM398025(US10322108, Example 22A)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398026BDBM398026(US10322108, Example 22B)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398019BDBM398019(US10322108, Example 19A)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398020BDBM398020(US10322108, Example 19B)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398040BDBM398040(US10322108, Example 36)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398041BDBM398041(US10322108, Example 37)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398038BDBM398038(US10322108, Example 34)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398034BDBM398034(US10322108, Example 30)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 397993BDBM397993(US10322108, Example 1)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 397995BDBM397995(US10322108, Example 2A)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398011BDBM398011(US10322108, Example 15A)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398012BDBM398012(US10322108, Example 15B)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398013BDBM398013(US10322108, Example 16A)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398014BDBM398014(US10322108, Example 16B)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398008BDBM398008(US10322108, Example 12)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398003BDBM398003(US10322108, Example 7)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398004BDBM398004(US10322108, Example 8)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398005BDBM398005(US10322108, Example 9)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398006BDBM398006(US10322108, Example 10)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 397999BDBM397999(US10322108, Example 3)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398000BDBM398000(US10322108, Example 4)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398001BDBM398001(US10322108, Example 5)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398002BDBM398002(US10322108, Example 6)
Affinity DataIC50: 100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398028BDBM398028(US10322108, Example 24)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398029BDBM398029(US10322108, Example 25)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398030BDBM398030(US10322108, Example 26)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 397996BDBM397996(US10322108, Example 2B)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398024BDBM398024(US10322108, Example 21B)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398021BDBM398021(US10322108, Example 20A)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398022BDBM398022(US10322108, Example 20B)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398015BDBM398015(US10322108, Example 17A)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398016BDBM398016(US10322108, Example 17B)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398039BDBM398039(US10322108, Example 35)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398007BDBM398007(US10322108, Example 11)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398009BDBM398009(US10322108, Example 13)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398010BDBM398010(US10322108, Example 14)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398032BDBM398032(US10322108, Example 28)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398033BDBM398033(US10322108, Example 29)
Affinity DataIC50: 550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398035BDBM398035(US10322108, Example 31)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398036BDBM398036(US10322108, Example 32)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398037BDBM398037(US10322108, Example 33)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398031BDBM398031(US10322108, Example 27)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398017BDBM398017(US10322108, Example 18A)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Beijing Hanmi Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 398018BDBM398018(US10322108, Example 18B)
Affinity DataIC50: 5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2020
Entry Details
US Patent